Skip to content

Diazyme DZ147A-CON

by Diazyme Laboratories, Inc.

Ref DZ147A-CON

Diazyme DZ147A-CON is a device classified as IVD General (EU), Class I (US) made by Diazyme Laboratories, Inc., registered in EUDAMED on 28 Oct 2026 (Basic UDI-DI B-DZ147A-CONP9), cleared under FDA 510(k) K123785 on 7 Jun 2013 and listed in FDA GUDID since 3 Nov 2016 (UDI-DI D-DZ147A-CONP9), active as of 7 Nov 2026.

Active European Union and United States. Also listed in GUDID (US).

CE IVDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 7 Nov 2026

Documents

None linked in EUDAMED

A group certificate may exist

510(k) K123785

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-DZ147A-CONP9 Basic UDI-DI D-DZ147A-CONP9UDI-DIDate28 Oct 2026RegisteredStatusActive
United StatesGUDID listing GUDID NumberD-DZ147A-CONP9 UDI-DI Date3 Nov 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK123785 Date7 Jun 2013DecidedStatusActive

Official records

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-DZ147A-CONP9 registered 28 Oct 2026 Active
  • FDA 510(k) K123785 decided 7 Jun 2013 Active
  • FDA GUDID UDI-DI D-DZ147A-CONP9 listed 3 Nov 2016 Listed

Timeline

3 dated events

  1. Cleared FDA 510(k) K123785
  2. Listed FDA GUDID D-DZ147A-CONP9
  3. Registered EUDAMED B-DZ147A-CONP9

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Diazyme Myoglobin Control Set EUDAMED
Diazyme GUDID
Generic name
Myoglobin IVD, control
Model / reference
DZ147A-CON
Primary DI / UDI-DI
D-DZ147A-CONP9 EUDAMED
00817089020634 GUDID
Basic UDI-DI
B-DZ147A-CONP9
510(k) Number
FDA product code
JJX, DDR
EMDN code
W0102152004 Cardiac marker controls
GMDN term
Myoglobin IVD, control
Device class
Class IVD General EUDAMED
Class I GUDID
Regulation number
862.1660, 866.5680
EU registration type
Legacy device (under a directive)
EU market of registration
Germany
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 2 fields differ

FieldEUDAMEDGUDID
Primary DI / UDI-DIEUDAMED
D-DZ147A-CONP9
GUDID
00817089020634
Device classEUDAMED
Class IVD General
GUDID
Class I

The registries describe this device under different primary UDI-DIs (EUDAMED lists D-DZ147A-CONP9; FDA GUDID lists 00817089020634), so their flags are not compared. Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Related devices

Category: Myoglobin IVD, control

Cleared under the same submission (K123785)

Similar devices in this category

Other devices filed under CARDIAC MARKER CONTROLS.

Other devices from Diazyme Laboratories, Inc.

See all devices from Diazyme Laboratories, Inc. →

Properties

  • Contains human tissues or cells
  • Professional testing
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (20, all answered No)